COVID-19 investigational vaccine: Clinical trials begin in Seattle
by Press Release from Outbreak News Today on (#50T71)
A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding the trial. KPWHRI is part of NIAID's Infectious Diseases Clinical ["]
The post COVID-19 investigational vaccine: Clinical trials begin in Seattle appeared first on Outbreak News Today.